Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 August 2004, Vol. 104, No. 4, pp. 1025-1033.
Prepublished online as a Blood First Edition Paper on May 4, 2004; DOI 10.1182/blood-2003-09-3334.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-09-3334v1
104/4/1025    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yuan, K.
Right arrow Articles by Lin, M. T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yuan, K.
Right arrow Articles by Lin, M. T
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted October 2, 2003
Accepted March 23, 2004

Syndecan-1 upregulated by ephrinB2/EphB4 plays dual roles in inflammatory angiogenesis

Kuo Yuan, Tse-Ming Hong, Jeremy Chen, Wan-Hua Tsai, and Ming T Lin*

Periodontics Division, Department of Dentistry, National Cheng Kung University Hospital, Tainan City, Taiwan; Department of Biochemistry and Institute of Basic Medical Sciences, Medical School, National Cheng Kung University, Tainan City, Taiwan
School of Pharmacy, Natinal Taiwan University College of Medicine, Taipei City, Taiwan
Institute of Biomedical Sciences and Molecular Biology, National Chung Hsing University, Taichung, Taiwan
Department of Biochemistry and Institute of Basic Medical Sciences, Medical School, National Cheng Kung University, Tainan City, Taiwan

* Corresponding author; email: Lin1223{at}mail.ncku.edu.tw.

EphrinB2 and EphB4, its cognate receptor, are important in the vascular development of the mouse embryo. Their roles in human inflammatory angiogenesis, however, are not well understood. By examining hyper-inflammatory lesions, we saw that ephrinB2 was predominantly expressed in macrophage-like cells, and EphB4, in small venules. Because macrophages usually transmigrate through post-capillary venules during inflammation, we wanted to explore the downstream effects of EphB4 after binding to ephrinB2. By using cDNA microarray technique and following RT-PCR, we found that syntenin and syndecan-1 were up-regulated in EphB4+ endothelial cells dose- and time-dependently after stimulation with pre-clustered ephrinB2. In vitro, ephrinB2 suppressed the angiogenic effects of bFGF on EphB4+ endothelial cells, partially due to syndecan-1's competition with FGFR for bFGF. However, ephrinB2 exhibited angiogenic effects in vivo, possibly due to an inflammation-associated enzyme-heparanase. The enzymes could convert the inhibitory effect of ephrinB2 on EphB4+ endothelial cells to an activating effect by removing poorly sulfated side chains of upregulated syndecan-1 ectodomain. Depending on the presence of heparanases, the roles of syndecan-1 may be opposite in different physiological settings.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
C. Cappuzzello, R. Melchionna, A. Mangoni, G. Tripodi, P. Ferrari, L. Torielli, D. Arcelli, M. Helmer-Citterich, G. Bianchi, M. C. Capogrossi, et al.
Role of rat {alpha} adducin in angiogenesis: Null effect of the F316Y polymorphism
Cardiovasc Res, August 1, 2007; 75(3): 608 - 617.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Mitola, M. Belleri, C. Urbinati, D. Coltrini, B. Sparatore, M. Pedrazzi, E. Melloni, and M. Presta
Cutting Edge: Extracellular High Mobility Group Box-1 Protein Is a Proangiogenic Cytokine
J. Immunol., January 1, 2006; 176(1): 12 - 15.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. Tkachenko, J. M. Rhodes, and M. Simons
Syndecans: New Kids on the Signaling Block
Circ. Res., March 18, 2005; 96(5): 488 - 500.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020